These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 29968693)
1. Prognostic factors in adrenocortical carcinoma: data from a large Polish series. Pellegriti G Pol Arch Intern Med; 2018 Jun; 128(6):330-332. PubMed ID: 29968693 [No Abstract] [Full Text] [Related]
2. Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature. Wanis KN; Kanthan R World J Surg Oncol; 2015 Mar; 13():117. PubMed ID: 25889798 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms. Mete O; Asa SL; Giordano TJ; Papotti M; Sasano H; Volante M Endocr Pathol; 2018 Jun; 29(2):137-149. PubMed ID: 29542002 [TBL] [Abstract][Full Text] [Related]
8. Adrenocortical carcinoma: a 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis. Orlando R; Pelizzo MR; Lirussi F Anticancer Res; 2003; 23(3C):2929-31. PubMed ID: 12926137 [TBL] [Abstract][Full Text] [Related]
10. Adrenocortical carcinoma with tumor thrombus in the right hepatic vein. Reyes MA; Ciancio G; Singal R; Manoharan M Int J Urol; 2006 Sep; 13(9):1233-5. PubMed ID: 16984559 [TBL] [Abstract][Full Text] [Related]
11. Adrenocortical carcinoma: prognostic indices based on clinical and immunohistochemical markers. Dichtchekenian V; de Bragança Pereira CA; Kuperman H; Della Manna T; Damiani D; Ferreira Alves VA; Filho AL; Setian N J Pediatr Endocrinol Metab; 2005 Apr; 18(4):347-53. PubMed ID: 15844468 [TBL] [Abstract][Full Text] [Related]
12. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E J Clin Endocrinol Metab; 2017 Sep; 102(9):3491-3498. PubMed ID: 28911143 [TBL] [Abstract][Full Text] [Related]
13. ASO Author Reflections: Additional Organ Resection in Adrenocortical Carcinoma. Marincola Smith P; Kiernan CM; Solórzano CC Ann Surg Oncol; 2018 Dec; 25(Suppl 3):872-873. PubMed ID: 30324471 [No Abstract] [Full Text] [Related]
15. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors. Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715 [TBL] [Abstract][Full Text] [Related]
16. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma. Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates. Duregon E; Volante M; Giorcelli J; Terzolo M; Lalli E; Papotti M Hum Pathol; 2013 May; 44(5):822-8. PubMed ID: 23158211 [TBL] [Abstract][Full Text] [Related]